RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011479 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Beth Osia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Genetics and Epigenetics, Beckman Research Institute of the City of Hope, Duarte, California, United States of America. Hauptthemen laut MEDLINE: Rad52 DNA Repair and Recombination Protein, Genomic Instability, Mitosis, DNA Helicases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Mammalian RAD52 is a DNA repair factor with strand annealing and recombination mediator activities that appear important in both interphase and mitotic cells. Nonetheless, RAD52 is dispensable for cell viability. To query RAD52 synthetic lethal relationships, we performed genome-wide CRISPR knock-out screens and identified hundreds of candidate synthetic lethal interactions. We then performed secondary screening and identified genes for which depletion causes reduced viability and elevated genome instability (increased 53BP1 nuclear foci) in RAD52-deficient cells. One such factor was ERCC6L, which marks DNA bridges during anaphase, and hence is important for genome stability in mitosis. Thus, we investigated the functional interrelationship between RAD52 and ERCC6L. We found that RAD52 deficiency increases ERCC6L-coated anaphase ultrafine bridges, and that ERCC6L depletion causes elevated RAD52 foci in prometaphase and interphase cells. These effects were enhanced with replication stress (i.e. hydroxyurea) and topoisomerase IIα inhibition (ICRF-193), where post-treatment effect timings were consistent with defects in addressing stress in mitosis. Altogether, we suggest that RAD52 and ERCC6L co-compensate to protect genome stability in mitosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cancer Genetics and Epigenetics, Beckman Research Institute of the City of Hope, Duarte, California, United States of America.
ORCID-Profile: Beth Osia, Felicia Wednesday Lopezcolorado, Jeremy M Stark
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Osia, B., Merkell, A., Lopezcolorado, F. W., Ping, X., & Stark, J. M. (2024). RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011479
Vancouver
Osia B, Merkell A, Lopezcolorado FW, Ping X, Stark JM. RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011479
BibTeX
@article{Osia2024,
author = {Osia, Beth and Merkell, Arianna and Lopezcolorado, Felicia Wednesday and Ping, Xiaoli and Stark, Jeremy M},
title = {RAD52 and ERCC6L/PICH have a compensatory relationship for genome stability in mitosis},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011479}
}
EUVIMED